Search results
Aug 5, 2022 · The recommended phototherapy thresholds (Figs 2 and 3; Supplemental Tables 1 and 2; Supplemental Figs 1 and 2) are far below those at which overt acute bilirubin neurotoxicity or kernicterus occurs. 9,26,87–95 Phototherapy should not be used solely with a goal of preventing subtle adverse neurodevelopmental findings, because the literature ...
AAP Technical Report: Diagnosis and Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Frequently Asked Questions About the 2022 AAP Guideline on the Management of Hyperbilirubinemia. Professional Tools & Resources. Key Driver Diagram for Hyperbilirubinemia.
specific charts such as AAP or NICE charts to evaluate need for treatment). • Look for lactation problems (excess weight loss and delayed transition of stool to yellow color), infrequent stool, and urine.
TSB should be done if TcB value is within 3mg/dL of phototherapy threshold or ≥15 mg/dL. New guidelines also advise to consider the rate of rise of bilirubin if multiple values of TcB or TSB are available, terming rise of 0.3 mg/dL/h in first 24 hours and 0.2 mg/dL/h thereafter as exceptional, indicating ≥.
Jul 1, 2004 · RECOMMENDATION 7.3: In breastfed infants who require phototherapy (Fig 3), the AAP recommends that, if possible, breastfeeding should be continued (evidence quality C: benefits exceed harms). It is also an option to interrupt temporarily breastfeeding and substitute formula.
Calculator and clinical decision support for the AAP 2022 guidelines for the management of hyperbilirubinemia in newborns 35 or more weeks of gestation. Features. Neurotoxicity risk factors absent, present, or both. Plot multiple time points to assess trends.
Aug 26, 2024 · This report outlines a standardized approach to the use of phototherapy consistent with the 2022 American Academy of Pediatrics (AAP) “Clinical Practice Guideline Revision for the Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation.” 1
The following graphs show follow-up recommendations by gestational age and presence of neurotoxicity risk factors, as recommended in Figure 7 of the 2022 AAP Hyperbilirubinemia Treatment Guideline. Thank you to Dr Thomas Newman for developing these graphs.
AAP 2022 Hyperbilirubinemia Management Guidelines Calculator and clinical decision support for the AAP 2022 guidelines for the management of hyperbilirubinemia in newborns 35 or more weeks of gestation.
Jan 10, 2024 · To help with implementation of the 2022 AAP guideline on the management of hyperbilirubinemia, members of the authoring group with input from other members of the AAP have put together this FAQ sheet. Please contact Alex Kemper if there is a common question that should be added.
